N/A
Completed N=294
Monitoring and Peer Support to Improve Treatment Adherence and Outcomes
Source: ClinicalTrials.gov NCT03446768 ↗Enrolled (actual)
294
Serious AEs
0.0%
Results posted
Dec 2021
Primary outcomePrimary: Change in CPAP Adherence at 6 Weeks — 7.4; 6.3 hours per night of CPAP use
Summary
The O2VERLAP study investigators would like to find out if individuals living with both COPD and OSA would benefit from an online, educational curriculum, coupled with access to peer support (i.e. telephone and online chatting with peers) and remote CPAP adherence monitoring data. The curriculum and peer coaching is meant to provide participants the information and tools they need to be more compliant in using their CPAP device.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in CPAP Adherence at 6 Weeks |
7.4; 6.3 | — |
| SECONDARY Change in Daytime Functioning at 6 and12 Weeks |
15.2; 14.6; 15.1; 14.6 | — |
Eligibility Criteria
Inclusion Criteria
- Age: >40 years
- Primary language: English
- Diagnosed with both Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA)
- Prescription for positive airway pressure therapy (PAP). There should be no minimum or maximum flow required (i.e., no limitation on PAP modality).
- Access to the internet viand a PC, tablet, or smart phone to complete all study activities from home or remotely
- PAP device with wireless modem
Exclusion Criteria
- Non-English speakers
- Life expectancy less than or equal to six months
Data sourced from ClinicalTrials.gov (NCT03446768). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.